Short answer · Medically reviewed summary · Last updated: 2026-05-08
Chronic myelogenous leukemia (CML) is most commonly referred to by that name or as chronic myeloid leukemia. While historical terms like chronic granulocytic leukemia exist in older medical literature, modern clinicians use these standardized terms to describe the same myeloproliferative neoplasm characterized by the Philadelphia chromosome. What are the common synonyms and historical names for CML? In clinical practice, Chronic myelogenous leukemia (CML) and chronic myeloid leukemia are used interchangeably.
Chronic myelogenous leukemia (CML) synonyms
Other names for Chronic myelogenous leukemia (CML): synonyms, acronyms and related terms used by doctors and patients.
Chronic myelogenous leukemia (CML) is most commonly referred to by that name or as chronic myeloid leukemia. While historical terms like chronic granulocytic leukemia exist in older medical literature, modern clinicians use these standardized terms to describe the same myeloproliferative neoplasm characterized by the Philadelphia chromosome.
What are the common synonyms and historical names for CML?
In clinical practice, Chronic myelogenous leukemia (CML) and chronic myeloid leukemia are used interchangeably. Historically, you may encounter the term chronic granulocytic leukemia in older textbooks or archival patient records. These names all describe the same condition where the bone marrow produces too many white blood cells. Because Chronic myelogenous leukemia (CML) is a well-defined molecular disease, terminology has become highly standardized compared to other conditions.
How is Chronic myelogenous leukemia (CML) classified officially?
Medical systems use specific codes to ensure consistency across international borders. In the International Classification of Diseases (ICD-10), Chronic myelogenous leukemia (CML) is categorized under code C92.1. In the Online Mendelian Inheritance in Man (OMIM) database, it is often referenced by its association with the BCR-ABL1 fusion gene. The following are the most recognized designations for the disease:
- Chronic myelogenous leukemia (CML) – Most common in US clinical settings.
- Chronic myeloid leukemia – Preferred in many international and European medical journals.
- Chronic granulocytic leukemia – An outdated term still found in legacy medical records.
- Ph+ CML – A shorthand used by oncologists to denote the presence of the Philadelphia chromosome.
Why does this condition have multiple names?
The evolution of names for Chronic myelogenous leukemia (CML) reflects shifts in medical understanding. Early clinicians named the disease based on the appearance of blood cells under a microscope (granulocytic). As our understanding evolved to focus on the origin of the cells in the bone marrow (myelogenous/myeloid), the terminology shifted. Today, Chronic myelogenous leukemia (CML) is defined by the specific genetic mutation known as the BCR-ABL1 fusion, which remains the gold standard for diagnosis regardless of the name used.
Next steps
- Review your pathology reports to confirm the specific terminology used by your hematologist.
- Join the 287 members of the Chronic myelogenous leukemia (CML) community at DiseaseMaps.org to share experiences.
- Consult a hematologist-oncologist to discuss your specific molecular profile and treatment plan.
Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.
References
- Orphanet: Chronic Myeloid Leukemia (ORPHA:520)
- NIH Genetic and Rare Diseases Information Center (GARD): Chronic Myelogenous Leukemia
- OMIM (Online Mendelian Inheritance in Man): #608232 Leukemia, Chronic Myeloid
- National Cancer Institute: Chronic Myelogenous Leukemia Treatment (PDQ®)
